Brainstorm Cell Therapeutics Inc. Stock Forecast
Big movements in Brainstorm Cell Therapeutics Inc. stock price on Monday moving 12.48% between high and low
(Updated on Apr 22, 2024)
The Brainstorm Cell Therapeutics Inc. stock price gained 1.52% on the last trading day (Monday, 22nd Apr 2024), rising from $0.532 to $0.540. During the last trading day the stock fluctuated 12.48% from a day low at $0.518 to a day high of $0.582. The price has been going up and down for this period, and there has been a -26.01% loss for the last 2 weeks. Volume fell on the last day by -633 thousand shares and in total, 363 thousand shares were bought and sold for approximately $196.21 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 65.42% during the next 3 months and, with a 90% probability hold a price between $0.750 and $1.35 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BCLI Signals & Forecast
A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -27.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Brainstorm Cell Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.541. On a fall, the stock will find some support from the long-term average at approximately $0.509. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.
Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock
Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.514 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0646 between high and low, or 12.48%. For the last week the stock has had daily average volatility of 23.28%.
Our recommended stop-loss: $0.508 (-5.88%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 15 days ago.)
Trading Expectations (BCLI) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect Brainstorm Cell Therapeutics Inc. to open at $0.547, and during the day (based on 14 day Average True Range), to move between $0.447 and $0.633, which gives a possible trading interval of +/-$0.0931 (+/-17.23%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 34.46% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.514 (4.78%) than the resistance at $0.570 (5.54%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Brainstorm Cell Therapeutics Inc. stock A Buy?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
Current score: 2.354 Buy Candidate Unchanged
Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Tuesday, April 23, 2024
Fair opening price April 23, 2024 | Current price |
---|---|
$0.547 ( 1.22%) | $0.540 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCLI
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.611 | 13.18 % | |
R2 | 0.587 | 8.61 % | ||
R1 | 0.571 | 5.79 % | ||
Current price: | 0.540 | |||
Support | S1 | 0.522 | -3.35 % | |
S2 | 0.507 | -6.17 % | ||
S3 | 0.482 | -10.74 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.655 | 21.27 % | |
R2 | 0.583 | 7.85 % | ||
R1 | 0.570 | 5.54 % | ||
Current price | 0.540 | |||
Support | S1 | 0.514 | -4.78% | |
S2 | 0.507 | -6.13% | ||
S3 | 0.480 | -11.13% |
FAQ
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.